Semler ScientificSMLR
SMLR
About: Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.
Employees: 79
0
Funds holding %
of 7,323 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
118% more call options, than puts
Call options by funds: $12.7M | Put options by funds: $5.81M
100% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 2 (+1) [Q1 2025]
100% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 25
80% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 20
13.71% more ownership
Funds ownership: 55.06% [Q4 2024] → 68.77% (+13.71%) [Q1 2025]
12% more funds holding
Funds holding: 110 [Q4 2024] → 123 (+13) [Q1 2025]
13% less capital invested
Capital invested by funds: $276M [Q4 2024] → $239M (-$36.6M) [Q1 2025]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$61
66%
upside
Avg. target
$86
133%
upside
High target
$101
174%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Cantor Fitzgerald Brett Knoblauch | 66%upside $61 | Overweight Initiated | 28 Jul 2025 |
Maxim Group Matt Galinko | 158%upside $95 | Buy Initiated | 9 Jul 2025 |
Benchmark Mark Palmer | 174%upside $101 | Buy Initiated | 8 Jul 2025 |
Financial journalist opinion
Based on 15 articles about SMLR published over the past 30 days
Neutral
GlobeNewsWire
17 hours ago
SEMLER INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Semler Scientific Inc. on Behalf of Semler Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options.
Neutral
GlobeNewsWire
1 day ago
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.
Neutral
PRNewsWire
4 days ago
Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR
NEW YORK , July 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. So What: If you purchased Semler Scientific securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Neutral
GlobeNewsWire
5 days ago
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.
Neutral
PRNewsWire
1 week ago
Semler Scientific® Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results
CAMPBELL, Calif. , July 21, 2025 /PRNewswire/ --Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced it will report financial results for the second quarter ended June 30, 2025, after the close of U.S. financial markets on Monday, August 4, 2025.
Neutral
GlobeNewsWire
1 week ago
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.
Neutral
PRNewsWire
1 week ago
Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR
NEW YORK , July 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public. So What: If you purchased Semler Scientific securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Neutral
GlobeNewsWire
1 week ago
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.
Positive
Schaeffers Research
2 weeks ago
135 Public Companies That Hold Bitcoin — And Why It Matters
Since the historic institutional pivot of 2020, Bitcoin has steadily made its way from fringe asset to mainstream corporate treasury tool.
Neutral
GlobeNewsWire
2 weeks ago
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Semler Scientific, Inc. (NASDAQ: SMLR) resulting from allegations that Semler Scientific may have issued materially misleading business information to the investing public.
Charts implemented using Lightweight Charts™